Steven Dyson was appointed Chairman of Unilabs’ board on 31st of January 2017.
Dr. Steven Dyson is a Partner in the Healthcare team and is based in London.
He joined Apax Partners in 2000 and has both led and participated in a number of key deals including Vyaire Medical, Invent Farma/neuraxpharm, GENEX, One Call Care Management, Acelity (formerly KCI), Capio, Unilabs, General Healthcare Group and Zeneus Pharma.
Prior to joining Apax Partners, Steven was a consultant with McKinsey & Company.
Steven holds a BA in Biochemistry from Oxford University and a PhD in Developmental Biology from Cambridge University.